[
  {
    "column": "S6",
    "description": "S6: How many years have you been in clinical practice, post residency/training?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "S8r1c1",
    "description": "S8r1c1: Treating/Managing patients - Approximately what percentage of your professional time is spent performing each of the following activities?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S8",
    "context": ""
  },
  {
    "column": "S8r2c1",
    "description": "S8r2c1: Performing academic functions (e.g., teaching, publishing) - Approximately what percentage of your professional time is spent performing each of the following activities?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S8",
    "context": ""
  },
  {
    "column": "S8r3c1",
    "description": "S8r3c1: Participating in clinical research - Approximately what percentage of your professional time is spent performing each of the following activities?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S8",
    "context": ""
  },
  {
    "column": "S8r4c1",
    "description": "S8r4c1: Performing other functions - Approximately what percentage of your professional time is spent performing each of the following activities?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S8",
    "context": ""
  },
  {
    "column": "S10r1",
    "description": "S10r1: Using your best estimate, how many adult patients, age 18 or older, do you personally manage in your practice in a month?By ‘personally’, we mean patients for whom you are a primary treatment decision maker.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S10",
    "context": ""
  },
  {
    "column": "S11r1",
    "description": "S11r1: Of those adult patients for whom you are the primary treatment decision maker, roughly how many have a confirmed diagnosis of hypercholesterolemia with established cardiovascular disease (CVD)?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S11",
    "context": ""
  },
  {
    "column": "S12W3r1",
    "description": "S12W3r1: Over 5 years ago - Of those, how many patients have had an event (MI, CAD, coronary revascularization, stent placement, etc.) …",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S12W3",
    "context": ""
  },
  {
    "column": "S12W3r2",
    "description": "S12W3r2: Within the last 3-5 years - Of those, how many patients have had an event (MI, CAD, coronary revascularization, stent placement, etc.) …",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S12W3",
    "context": ""
  },
  {
    "column": "S12W3r3",
    "description": "S12W3r3: Within the 1-2 years - Of those, how many patients have had an event (MI, CAD, coronary revascularization, stent placement, etc.) …",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S12W3",
    "context": ""
  },
  {
    "column": "S12W3r4",
    "description": "S12W3r4: Within the last year - Of those, how many patients have had an event (MI, CAD, coronary revascularization, stent placement, etc.) …",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S12W3",
    "context": ""
  },
  {
    "column": "S12r1c1",
    "description": "S12r1c1: Atherosclerotic Cardiovascular Disease (ASCVD) - Of those adult patients, how many have been diagnosed with…?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S12",
    "context": ""
  },
  {
    "column": "S12r2c1",
    "description": "S12r2c1: Familial Hypercholesterolemia (FH) - Of those adult patients, how many have been diagnosed with…?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S12",
    "context": ""
  },
  {
    "column": "S12r3c1",
    "description": "S12r3c1: Other primary prevention related conditions that require prescription drug therapy to lower LDL-C - Of those adult patients, how many have been diagnosed with…?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S12",
    "context": ""
  },
  {
    "column": "S13r1c1",
    "description": "S13r1c1: # of patients - Atherosclerotic Cardiovascular Disease (ASCVD) - Thinking of the adult patients currently on prescription drug therapy for ASCVD, for how many of them are you the primary treatment decision maker?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S13",
    "context": ""
  },
  {
    "column": "S13r1c2",
    "description": "S13r1c2: # of patients on prescription drug therapy for whom you are the primary treatment decision maker - Atherosclerotic Cardiovascular Disease (ASCVD) - Thinking of the adult patients currently on prescription drug therapy for ASCVD, for how many of t",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S13",
    "context": ""
  },
  {
    "column": "S13r2c1",
    "description": "S13r2c1: # of patients - Familial Hypercholesterolemia (FH) - Thinking of the adult patients currently on prescription drug therapy for ASCVD, for how many of them are you the primary treatment decision maker?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S13",
    "context": ""
  },
  {
    "column": "S13r2c2",
    "description": "S13r2c2: # of patients on prescription drug therapy for whom you are the primary treatment decision maker - Familial Hypercholesterolemia (FH) - Thinking of the adult patients currently on prescription drug therapy for ASCVD, for how many of them are you",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S13",
    "context": ""
  },
  {
    "column": "S13r3c1",
    "description": "S13r3c1: # of patients - Other primary prevention related conditions that require prescription drug therapy to lower LDL-C - Thinking of the adult patients currently on prescription drug therapy for ASCVD, for how many of them are you the primary treatmen",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S13",
    "context": ""
  },
  {
    "column": "S13r3c2",
    "description": "S13r3c2: # of patients on prescription drug therapy for whom you are the primary treatment decision maker - Other primary prevention related conditions that require prescription drug therapy to lower LDL-C - Thinking of the adult patients currently on pre",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S13",
    "context": ""
  },
  {
    "column": "A1a",
    "description": "A1a: In total, approximately how many adult patients are you currently managing with elevated LDL-C?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "A1dr1",
    "description": "A1dr1: Diet & Exercise alone - Of those adult patients with elevated LDL-C, what % are managed with …?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1d",
    "context": ""
  },
  {
    "column": "A1dr2",
    "description": "A1dr2: Prescription Treatment for LDL-C along with Diet & Exercise - Of those adult patients with elevated LDL-C, what % are managed with …?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1d",
    "context": ""
  },
  {
    "column": "A1er1",
    "description": "A1er1: Familial Hypercholesterolemia (with or without a prior history of a CV event) - Of those adult patients with elevated LDL-C who are currently treated with prescription treatment along with diet and exercise, what % are in each of the following cate",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1e",
    "context": ""
  },
  {
    "column": "A1er2",
    "description": "A1er2: No prior history of a CV event (and no FH) - Of those adult patients with elevated LDL-C who are currently treated with prescription treatment along with diet and exercise, what % are in each of the following categories?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1e",
    "context": ""
  },
  {
    "column": "A1er3",
    "description": "A1er3: Prior history of a CV event (and no FH) - Of those adult patients with elevated LDL-C who are currently treated with prescription treatment along with diet and exercise, what % are in each of the following categories?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1e",
    "context": ""
  },
  {
    "column": "A1dar1",
    "description": "A1dar1: What % are at low to medium risk for a CV event? - Of those adult patients with elevated LDL-C who are currently treated with prescription treatment along with diet and exercise and had no prior history of a CV event (and no FH), what % are in eac",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1da",
    "context": ""
  },
  {
    "column": "A1dar2",
    "description": "A1dar2: What % are at high risk for a CV event? - Of those adult patients with elevated LDL-C who are currently treated with prescription treatment along with diet and exercise and had no prior history of a CV event (and no FH), what % are in each of the",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1da",
    "context": ""
  },
  {
    "column": "T",
    "description": "T: # of patients with high-LDC treated with prescriptions",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "PT1",
    "description": "PT1: Patient type 1 (prior event or no prior event but high risk)",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "PT2",
    "description": "PT2: Patient type 2 (no prior event and low-to-med risk)",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "A1fr1",
    "description": "A1fr1: CAD - Of those adult patients with elevated LDL-C who are currently treated with prescription treatment along with diet and exercise and have had a prior CV event, what % are in each of the following categories?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1f",
    "context": ""
  },
  {
    "column": "A1fr2",
    "description": "A1fr2: PAD - Of those adult patients with elevated LDL-C who are currently treated with prescription treatment along with diet and exercise and have had a prior CV event, what % are in each of the following categories?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1f",
    "context": ""
  },
  {
    "column": "A1fr3",
    "description": "A1fr3: Revascularization - Of those adult patients with elevated LDL-C who are currently treated with prescription treatment along with diet and exercise and have had a prior CV event, what % are in each of the following categories?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A1f",
    "context": ""
  },
  {
    "column": "A1",
    "description": "A1: Approximately how many TOTAL adult patients do you have with (e.g., MI, stroke, or symptomatic PAD)?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "A1a_1",
    "description": "A1a_1: What percentage of your adult patients with require additional therapy on top of maximally tolerated statin therapy to lower LDL-C and/or to reduce the risk of future CV events?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "A1b",
    "description": "A1b: Approximately how many TOTAL adult patients do you have with ?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "A1c",
    "description": "A1c: What percentage of your adult patients with require additional lowering of LDL-C on top of maximally tolerated statin therapy?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "A3r1c1",
    "description": "A3r1c1: Leqvio (inclisiran) - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r2c1",
    "description": "A3r2c1: Praluent (alirocumab) - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each o",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r3c1",
    "description": "A3r3c1: Repatha (evolocumab) - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r4c1",
    "description": "A3r4c1: Zetia (ezetimibe) or generic - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r5c1",
    "description": "A3r5c1: Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe) - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r6c1",
    "description": "A3r6c1: Other - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of the following",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r7c1",
    "description": "A3r7c1: No additional therapy - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each o",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r1c2",
    "description": "A3r1c2: Leqvio (inclisiran) - Adults with low to medium risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of the following treatments? Please keep",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r2c2",
    "description": "A3r2c2: Praluent (alirocumab) - Adults with low to medium risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of the following treatments? Please ke",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r3c2",
    "description": "A3r3c2: Repatha (evolocumab) - Adults with low to medium risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of the following treatments? Please kee",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r4c2",
    "description": "A3r4c2: Zetia (ezetimibe) or generic - Adults with low to medium risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of the following treatments? Pl",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r5c2",
    "description": "A3r5c2: Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe) - Adults with low to medium risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescr",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r6c2",
    "description": "A3r6c2: Other - Adults with low to medium risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of the following treatments? Please keep in mind that",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A3r7c2",
    "description": "A3r7c2: No additional therapy - Adults with low to medium risk for CV events (without a prior event) - For your NEXT 100 patients with uncontrolled LDL-C in each of those groups, for how many would you prescribe each of the following treatments? Please ke",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A3",
    "context": ""
  },
  {
    "column": "A5r1c1",
    "description": "A5r1c1: Leqvio (inclisiran) - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receive",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r2c1",
    "description": "A5r2c1: Praluent (alirocumab) - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receiv",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r3c1",
    "description": "A5r3c1: Repatha (evolocumab) - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receive",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r4c1",
    "description": "A5r4c1: Zetia (ezetimibe) or generic - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r5c1",
    "description": "A5r5c1: Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe) - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r6c1",
    "description": "A5r6c1: Other - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receive additional adv",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r7c1",
    "description": "A5r7c1: No additional therapy - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receiv",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r1c2",
    "description": "A5r1c2: Leqvio (inclisiran) - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patie",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r2c2",
    "description": "A5r2c2: Praluent (alirocumab) - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many pat",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r3c2",
    "description": "A5r3c2: Repatha (evolocumab) - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many pati",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r4c2",
    "description": "A5r4c2: Zetia (ezetimibe) or generic - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that m",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r5c2",
    "description": "A5r5c2: Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe) - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the followi",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r6c2",
    "description": "A5r6c2: Other - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do n",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r7c2",
    "description": "A5r7c2: No additional therapy - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many pat",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r1c3",
    "description": "A5r1c3: Leqvio (inclisiran) - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receive",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r2c3",
    "description": "A5r2c3: Praluent (alirocumab) - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receiv",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r3c3",
    "description": "A5r3c3: Repatha (evolocumab) - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receive",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r4c3",
    "description": "A5r4c3: Zetia (ezetimibe) or generic - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r5c3",
    "description": "A5r5c3: Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe) - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r6c3",
    "description": "A5r6c3: Other - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receive additional adv",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r7c3",
    "description": "A5r7c3: No additional therapy - Current Prescribing - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do not receiv",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r1c4",
    "description": "A5r1c4: Leqvio (inclisiran) - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patie",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r2c4",
    "description": "A5r2c4: Praluent (alirocumab) - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many pat",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r3c4",
    "description": "A5r3c4: Repatha (evolocumab) - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many pati",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r4c4",
    "description": "A5r4c4: Zetia (ezetimibe) or generic - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that m",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r5c4",
    "description": "A5r5c4: Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe) - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the followi",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r6c4",
    "description": "A5r6c4: Other - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many patients often do n",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "A5r7c4",
    "description": "A5r7c4: No additional therapy - Near Future with any Leqvio issues addressed - With all of that in mind, for your NEXT 100 patients in each of the same groups, how many would you prescribe each of the following treatments?Please keep in mind that many pat",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "A5",
    "context": ""
  },
  {
    "column": "B3_1r1c1",
    "description": "B3_1r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r2c1",
    "description": "B3_1r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r3c1",
    "description": "B3_1r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r4c1",
    "description": "B3_1r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r5c1",
    "description": "B3_1r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r6c1",
    "description": "B3_1r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r7c1",
    "description": "B3_1r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r8c1",
    "description": "B3_1r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r9c1",
    "description": "B3_1r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r10c1",
    "description": "B3_1r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r11c1",
    "description": "B3_1r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r1c2",
    "description": "B3_1r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r2c2",
    "description": "B3_1r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r3c2",
    "description": "B3_1r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r4c2",
    "description": "B3_1r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r5c2",
    "description": "B3_1r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r6c2",
    "description": "B3_1r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r7c2",
    "description": "B3_1r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r8c2",
    "description": "B3_1r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r9c2",
    "description": "B3_1r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r10c2",
    "description": "B3_1r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r11c2",
    "description": "B3_1r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_1",
    "context": ""
  },
  {
    "column": "B3_1r1dum1",
    "description": "B3_1r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r2dum1",
    "description": "B3_1r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r3dum1",
    "description": "B3_1r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r4dum1",
    "description": "B3_1r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r5dum1",
    "description": "B3_1r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r6dum1",
    "description": "B3_1r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r7dum1",
    "description": "B3_1r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r8dum1",
    "description": "B3_1r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r9dum1",
    "description": "B3_1r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r10dum1",
    "description": "B3_1r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r11dum1",
    "description": "B3_1r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r1dum2",
    "description": "B3_1r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r2dum2",
    "description": "B3_1r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r3dum2",
    "description": "B3_1r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r4dum2",
    "description": "B3_1r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r5dum2",
    "description": "B3_1r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r6dum2",
    "description": "B3_1r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r7dum2",
    "description": "B3_1r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r8dum2",
    "description": "B3_1r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r9dum2",
    "description": "B3_1r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r10dum2",
    "description": "B3_1r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r11dum2",
    "description": "B3_1r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r1dum3",
    "description": "B3_1r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r2dum3",
    "description": "B3_1r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r3dum3",
    "description": "B3_1r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r4dum3",
    "description": "B3_1r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r5dum3",
    "description": "B3_1r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r6dum3",
    "description": "B3_1r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r7dum3",
    "description": "B3_1r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r8dum3",
    "description": "B3_1r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r9dum3",
    "description": "B3_1r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r10dum3",
    "description": "B3_1r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r11dum3",
    "description": "B3_1r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r1dum4",
    "description": "B3_1r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r2dum4",
    "description": "B3_1r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r3dum4",
    "description": "B3_1r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r4dum4",
    "description": "B3_1r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r5dum4",
    "description": "B3_1r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r6dum4",
    "description": "B3_1r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r7dum4",
    "description": "B3_1r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r8dum4",
    "description": "B3_1r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r9dum4",
    "description": "B3_1r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r10dum4",
    "description": "B3_1r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r11dum4",
    "description": "B3_1r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r1dum5",
    "description": "B3_1r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r2dum5",
    "description": "B3_1r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r3dum5",
    "description": "B3_1r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r4dum5",
    "description": "B3_1r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r5dum5",
    "description": "B3_1r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r6dum5",
    "description": "B3_1r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r7dum5",
    "description": "B3_1r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r8dum5",
    "description": "B3_1r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r9dum5",
    "description": "B3_1r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r10dum5",
    "description": "B3_1r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_1r11dum5",
    "description": "B3_1r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r1c1",
    "description": "B3_2r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r2c1",
    "description": "B3_2r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r3c1",
    "description": "B3_2r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r4c1",
    "description": "B3_2r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r5c1",
    "description": "B3_2r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r6c1",
    "description": "B3_2r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r7c1",
    "description": "B3_2r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r8c1",
    "description": "B3_2r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r9c1",
    "description": "B3_2r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r10c1",
    "description": "B3_2r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r11c1",
    "description": "B3_2r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r1c2",
    "description": "B3_2r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r2c2",
    "description": "B3_2r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r3c2",
    "description": "B3_2r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r4c2",
    "description": "B3_2r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r5c2",
    "description": "B3_2r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r6c2",
    "description": "B3_2r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r7c2",
    "description": "B3_2r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r8c2",
    "description": "B3_2r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r9c2",
    "description": "B3_2r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r10c2",
    "description": "B3_2r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r11c2",
    "description": "B3_2r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_2",
    "context": ""
  },
  {
    "column": "B3_2r1dum1",
    "description": "B3_2r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r2dum1",
    "description": "B3_2r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r3dum1",
    "description": "B3_2r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r4dum1",
    "description": "B3_2r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r5dum1",
    "description": "B3_2r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r6dum1",
    "description": "B3_2r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r7dum1",
    "description": "B3_2r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r8dum1",
    "description": "B3_2r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r9dum1",
    "description": "B3_2r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r10dum1",
    "description": "B3_2r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r11dum1",
    "description": "B3_2r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r1dum2",
    "description": "B3_2r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r2dum2",
    "description": "B3_2r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r3dum2",
    "description": "B3_2r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r4dum2",
    "description": "B3_2r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r5dum2",
    "description": "B3_2r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r6dum2",
    "description": "B3_2r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r7dum2",
    "description": "B3_2r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r8dum2",
    "description": "B3_2r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r9dum2",
    "description": "B3_2r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r10dum2",
    "description": "B3_2r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r11dum2",
    "description": "B3_2r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r1dum3",
    "description": "B3_2r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r2dum3",
    "description": "B3_2r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r3dum3",
    "description": "B3_2r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r4dum3",
    "description": "B3_2r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r5dum3",
    "description": "B3_2r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r6dum3",
    "description": "B3_2r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r7dum3",
    "description": "B3_2r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r8dum3",
    "description": "B3_2r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r9dum3",
    "description": "B3_2r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r10dum3",
    "description": "B3_2r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r11dum3",
    "description": "B3_2r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r1dum4",
    "description": "B3_2r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r2dum4",
    "description": "B3_2r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r3dum4",
    "description": "B3_2r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r4dum4",
    "description": "B3_2r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r5dum4",
    "description": "B3_2r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r6dum4",
    "description": "B3_2r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r7dum4",
    "description": "B3_2r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r8dum4",
    "description": "B3_2r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r9dum4",
    "description": "B3_2r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r10dum4",
    "description": "B3_2r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r11dum4",
    "description": "B3_2r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r1dum5",
    "description": "B3_2r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r2dum5",
    "description": "B3_2r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r3dum5",
    "description": "B3_2r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r4dum5",
    "description": "B3_2r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r5dum5",
    "description": "B3_2r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r6dum5",
    "description": "B3_2r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r7dum5",
    "description": "B3_2r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r8dum5",
    "description": "B3_2r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r9dum5",
    "description": "B3_2r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r10dum5",
    "description": "B3_2r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_2r11dum5",
    "description": "B3_2r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r1c1",
    "description": "B3_3r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r2c1",
    "description": "B3_3r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r3c1",
    "description": "B3_3r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r4c1",
    "description": "B3_3r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r5c1",
    "description": "B3_3r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r6c1",
    "description": "B3_3r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r7c1",
    "description": "B3_3r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r8c1",
    "description": "B3_3r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r9c1",
    "description": "B3_3r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r10c1",
    "description": "B3_3r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r11c1",
    "description": "B3_3r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r1c2",
    "description": "B3_3r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r2c2",
    "description": "B3_3r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r3c2",
    "description": "B3_3r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r4c2",
    "description": "B3_3r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r5c2",
    "description": "B3_3r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r6c2",
    "description": "B3_3r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r7c2",
    "description": "B3_3r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r8c2",
    "description": "B3_3r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r9c2",
    "description": "B3_3r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r10c2",
    "description": "B3_3r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r11c2",
    "description": "B3_3r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_3",
    "context": ""
  },
  {
    "column": "B3_3r1dum1",
    "description": "B3_3r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r2dum1",
    "description": "B3_3r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r3dum1",
    "description": "B3_3r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r4dum1",
    "description": "B3_3r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r5dum1",
    "description": "B3_3r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r6dum1",
    "description": "B3_3r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r7dum1",
    "description": "B3_3r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r8dum1",
    "description": "B3_3r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r9dum1",
    "description": "B3_3r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r10dum1",
    "description": "B3_3r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r11dum1",
    "description": "B3_3r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r1dum2",
    "description": "B3_3r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r2dum2",
    "description": "B3_3r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r3dum2",
    "description": "B3_3r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r4dum2",
    "description": "B3_3r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r5dum2",
    "description": "B3_3r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r6dum2",
    "description": "B3_3r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r7dum2",
    "description": "B3_3r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r8dum2",
    "description": "B3_3r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r9dum2",
    "description": "B3_3r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r10dum2",
    "description": "B3_3r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r11dum2",
    "description": "B3_3r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r1dum3",
    "description": "B3_3r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r2dum3",
    "description": "B3_3r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r3dum3",
    "description": "B3_3r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r4dum3",
    "description": "B3_3r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r5dum3",
    "description": "B3_3r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r6dum3",
    "description": "B3_3r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r7dum3",
    "description": "B3_3r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r8dum3",
    "description": "B3_3r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r9dum3",
    "description": "B3_3r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r10dum3",
    "description": "B3_3r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r11dum3",
    "description": "B3_3r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r1dum4",
    "description": "B3_3r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r2dum4",
    "description": "B3_3r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r3dum4",
    "description": "B3_3r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r4dum4",
    "description": "B3_3r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r5dum4",
    "description": "B3_3r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r6dum4",
    "description": "B3_3r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r7dum4",
    "description": "B3_3r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r8dum4",
    "description": "B3_3r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r9dum4",
    "description": "B3_3r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r10dum4",
    "description": "B3_3r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r11dum4",
    "description": "B3_3r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r1dum5",
    "description": "B3_3r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r2dum5",
    "description": "B3_3r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r3dum5",
    "description": "B3_3r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r4dum5",
    "description": "B3_3r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r5dum5",
    "description": "B3_3r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r6dum5",
    "description": "B3_3r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r7dum5",
    "description": "B3_3r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r8dum5",
    "description": "B3_3r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r9dum5",
    "description": "B3_3r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r10dum5",
    "description": "B3_3r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_3r11dum5",
    "description": "B3_3r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r1c1",
    "description": "B3_4r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r2c1",
    "description": "B3_4r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r3c1",
    "description": "B3_4r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r4c1",
    "description": "B3_4r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r5c1",
    "description": "B3_4r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r6c1",
    "description": "B3_4r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r7c1",
    "description": "B3_4r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r8c1",
    "description": "B3_4r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r9c1",
    "description": "B3_4r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r10c1",
    "description": "B3_4r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r11c1",
    "description": "B3_4r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r1c2",
    "description": "B3_4r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r2c2",
    "description": "B3_4r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r3c2",
    "description": "B3_4r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r4c2",
    "description": "B3_4r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r5c2",
    "description": "B3_4r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r6c2",
    "description": "B3_4r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r7c2",
    "description": "B3_4r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r8c2",
    "description": "B3_4r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r9c2",
    "description": "B3_4r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r10c2",
    "description": "B3_4r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r11c2",
    "description": "B3_4r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_4",
    "context": ""
  },
  {
    "column": "B3_4r1dum1",
    "description": "B3_4r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r2dum1",
    "description": "B3_4r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r3dum1",
    "description": "B3_4r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r4dum1",
    "description": "B3_4r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r5dum1",
    "description": "B3_4r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r6dum1",
    "description": "B3_4r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r7dum1",
    "description": "B3_4r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r8dum1",
    "description": "B3_4r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r9dum1",
    "description": "B3_4r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r10dum1",
    "description": "B3_4r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r11dum1",
    "description": "B3_4r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r1dum2",
    "description": "B3_4r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r2dum2",
    "description": "B3_4r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r3dum2",
    "description": "B3_4r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r4dum2",
    "description": "B3_4r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r5dum2",
    "description": "B3_4r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r6dum2",
    "description": "B3_4r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r7dum2",
    "description": "B3_4r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r8dum2",
    "description": "B3_4r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r9dum2",
    "description": "B3_4r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r10dum2",
    "description": "B3_4r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r11dum2",
    "description": "B3_4r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r1dum3",
    "description": "B3_4r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r2dum3",
    "description": "B3_4r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r3dum3",
    "description": "B3_4r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r4dum3",
    "description": "B3_4r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r5dum3",
    "description": "B3_4r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r6dum3",
    "description": "B3_4r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r7dum3",
    "description": "B3_4r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r8dum3",
    "description": "B3_4r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r9dum3",
    "description": "B3_4r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r10dum3",
    "description": "B3_4r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r11dum3",
    "description": "B3_4r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r1dum4",
    "description": "B3_4r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r2dum4",
    "description": "B3_4r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r3dum4",
    "description": "B3_4r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r4dum4",
    "description": "B3_4r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r5dum4",
    "description": "B3_4r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r6dum4",
    "description": "B3_4r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r7dum4",
    "description": "B3_4r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r8dum4",
    "description": "B3_4r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r9dum4",
    "description": "B3_4r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r10dum4",
    "description": "B3_4r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r11dum4",
    "description": "B3_4r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r1dum5",
    "description": "B3_4r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r2dum5",
    "description": "B3_4r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r3dum5",
    "description": "B3_4r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r4dum5",
    "description": "B3_4r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r5dum5",
    "description": "B3_4r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r6dum5",
    "description": "B3_4r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r7dum5",
    "description": "B3_4r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r8dum5",
    "description": "B3_4r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r9dum5",
    "description": "B3_4r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r10dum5",
    "description": "B3_4r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_4r11dum5",
    "description": "B3_4r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r1c1",
    "description": "B3_5r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r2c1",
    "description": "B3_5r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r3c1",
    "description": "B3_5r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r4c1",
    "description": "B3_5r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r5c1",
    "description": "B3_5r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r6c1",
    "description": "B3_5r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r7c1",
    "description": "B3_5r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r8c1",
    "description": "B3_5r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r9c1",
    "description": "B3_5r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r10c1",
    "description": "B3_5r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r11c1",
    "description": "B3_5r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r1c2",
    "description": "B3_5r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r2c2",
    "description": "B3_5r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r3c2",
    "description": "B3_5r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r4c2",
    "description": "B3_5r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r5c2",
    "description": "B3_5r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r6c2",
    "description": "B3_5r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r7c2",
    "description": "B3_5r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r8c2",
    "description": "B3_5r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r9c2",
    "description": "B3_5r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r10c2",
    "description": "B3_5r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r11c2",
    "description": "B3_5r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_5",
    "context": ""
  },
  {
    "column": "B3_5r1dum1",
    "description": "B3_5r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r2dum1",
    "description": "B3_5r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r3dum1",
    "description": "B3_5r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r4dum1",
    "description": "B3_5r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r5dum1",
    "description": "B3_5r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r6dum1",
    "description": "B3_5r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r7dum1",
    "description": "B3_5r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r8dum1",
    "description": "B3_5r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r9dum1",
    "description": "B3_5r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r10dum1",
    "description": "B3_5r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r11dum1",
    "description": "B3_5r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r1dum2",
    "description": "B3_5r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r2dum2",
    "description": "B3_5r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r3dum2",
    "description": "B3_5r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r4dum2",
    "description": "B3_5r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r5dum2",
    "description": "B3_5r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r6dum2",
    "description": "B3_5r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r7dum2",
    "description": "B3_5r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r8dum2",
    "description": "B3_5r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r9dum2",
    "description": "B3_5r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r10dum2",
    "description": "B3_5r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r11dum2",
    "description": "B3_5r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r1dum3",
    "description": "B3_5r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r2dum3",
    "description": "B3_5r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r3dum3",
    "description": "B3_5r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r4dum3",
    "description": "B3_5r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r5dum3",
    "description": "B3_5r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r6dum3",
    "description": "B3_5r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r7dum3",
    "description": "B3_5r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r8dum3",
    "description": "B3_5r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r9dum3",
    "description": "B3_5r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r10dum3",
    "description": "B3_5r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r11dum3",
    "description": "B3_5r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r1dum4",
    "description": "B3_5r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r2dum4",
    "description": "B3_5r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r3dum4",
    "description": "B3_5r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r4dum4",
    "description": "B3_5r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r5dum4",
    "description": "B3_5r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r6dum4",
    "description": "B3_5r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r7dum4",
    "description": "B3_5r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r8dum4",
    "description": "B3_5r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r9dum4",
    "description": "B3_5r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r10dum4",
    "description": "B3_5r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r11dum4",
    "description": "B3_5r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r1dum5",
    "description": "B3_5r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r2dum5",
    "description": "B3_5r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r3dum5",
    "description": "B3_5r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r4dum5",
    "description": "B3_5r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r5dum5",
    "description": "B3_5r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r6dum5",
    "description": "B3_5r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r7dum5",
    "description": "B3_5r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r8dum5",
    "description": "B3_5r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r9dum5",
    "description": "B3_5r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r10dum5",
    "description": "B3_5r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_5r11dum5",
    "description": "B3_5r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r1c1",
    "description": "B3_6r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r2c1",
    "description": "B3_6r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r3c1",
    "description": "B3_6r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r4c1",
    "description": "B3_6r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r5c1",
    "description": "B3_6r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r6c1",
    "description": "B3_6r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r7c1",
    "description": "B3_6r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r8c1",
    "description": "B3_6r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r9c1",
    "description": "B3_6r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r10c1",
    "description": "B3_6r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r11c1",
    "description": "B3_6r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r1c2",
    "description": "B3_6r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r2c2",
    "description": "B3_6r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r3c2",
    "description": "B3_6r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r4c2",
    "description": "B3_6r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r5c2",
    "description": "B3_6r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r6c2",
    "description": "B3_6r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r7c2",
    "description": "B3_6r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r8c2",
    "description": "B3_6r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r9c2",
    "description": "B3_6r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r10c2",
    "description": "B3_6r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r11c2",
    "description": "B3_6r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_6",
    "context": ""
  },
  {
    "column": "B3_6r1dum1",
    "description": "B3_6r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r2dum1",
    "description": "B3_6r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r3dum1",
    "description": "B3_6r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r4dum1",
    "description": "B3_6r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r5dum1",
    "description": "B3_6r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r6dum1",
    "description": "B3_6r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r7dum1",
    "description": "B3_6r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r8dum1",
    "description": "B3_6r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r9dum1",
    "description": "B3_6r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r10dum1",
    "description": "B3_6r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r11dum1",
    "description": "B3_6r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r1dum2",
    "description": "B3_6r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r2dum2",
    "description": "B3_6r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r3dum2",
    "description": "B3_6r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r4dum2",
    "description": "B3_6r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r5dum2",
    "description": "B3_6r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r6dum2",
    "description": "B3_6r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r7dum2",
    "description": "B3_6r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r8dum2",
    "description": "B3_6r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r9dum2",
    "description": "B3_6r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r10dum2",
    "description": "B3_6r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r11dum2",
    "description": "B3_6r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r1dum3",
    "description": "B3_6r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r2dum3",
    "description": "B3_6r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r3dum3",
    "description": "B3_6r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r4dum3",
    "description": "B3_6r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r5dum3",
    "description": "B3_6r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r6dum3",
    "description": "B3_6r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r7dum3",
    "description": "B3_6r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r8dum3",
    "description": "B3_6r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r9dum3",
    "description": "B3_6r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r10dum3",
    "description": "B3_6r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r11dum3",
    "description": "B3_6r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r1dum4",
    "description": "B3_6r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r2dum4",
    "description": "B3_6r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r3dum4",
    "description": "B3_6r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r4dum4",
    "description": "B3_6r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r5dum4",
    "description": "B3_6r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r6dum4",
    "description": "B3_6r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r7dum4",
    "description": "B3_6r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r8dum4",
    "description": "B3_6r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r9dum4",
    "description": "B3_6r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r10dum4",
    "description": "B3_6r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r11dum4",
    "description": "B3_6r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r1dum5",
    "description": "B3_6r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r2dum5",
    "description": "B3_6r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r3dum5",
    "description": "B3_6r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r4dum5",
    "description": "B3_6r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r5dum5",
    "description": "B3_6r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r6dum5",
    "description": "B3_6r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r7dum5",
    "description": "B3_6r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r8dum5",
    "description": "B3_6r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r9dum5",
    "description": "B3_6r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r10dum5",
    "description": "B3_6r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_6r11dum5",
    "description": "B3_6r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r1c1",
    "description": "B3_7r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r2c1",
    "description": "B3_7r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r3c1",
    "description": "B3_7r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r4c1",
    "description": "B3_7r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r5c1",
    "description": "B3_7r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r6c1",
    "description": "B3_7r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r7c1",
    "description": "B3_7r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r8c1",
    "description": "B3_7r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r9c1",
    "description": "B3_7r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r10c1",
    "description": "B3_7r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r11c1",
    "description": "B3_7r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r1c2",
    "description": "B3_7r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r2c2",
    "description": "B3_7r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r3c2",
    "description": "B3_7r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r4c2",
    "description": "B3_7r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r5c2",
    "description": "B3_7r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r6c2",
    "description": "B3_7r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r7c2",
    "description": "B3_7r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r8c2",
    "description": "B3_7r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r9c2",
    "description": "B3_7r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r10c2",
    "description": "B3_7r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r11c2",
    "description": "B3_7r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_7",
    "context": ""
  },
  {
    "column": "B3_7r1dum1",
    "description": "B3_7r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r2dum1",
    "description": "B3_7r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r3dum1",
    "description": "B3_7r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r4dum1",
    "description": "B3_7r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r5dum1",
    "description": "B3_7r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r6dum1",
    "description": "B3_7r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r7dum1",
    "description": "B3_7r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r8dum1",
    "description": "B3_7r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r9dum1",
    "description": "B3_7r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r10dum1",
    "description": "B3_7r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r11dum1",
    "description": "B3_7r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r1dum2",
    "description": "B3_7r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r2dum2",
    "description": "B3_7r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r3dum2",
    "description": "B3_7r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r4dum2",
    "description": "B3_7r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r5dum2",
    "description": "B3_7r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r6dum2",
    "description": "B3_7r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r7dum2",
    "description": "B3_7r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r8dum2",
    "description": "B3_7r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r9dum2",
    "description": "B3_7r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r10dum2",
    "description": "B3_7r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r11dum2",
    "description": "B3_7r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r1dum3",
    "description": "B3_7r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r2dum3",
    "description": "B3_7r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r3dum3",
    "description": "B3_7r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r4dum3",
    "description": "B3_7r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r5dum3",
    "description": "B3_7r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r6dum3",
    "description": "B3_7r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r7dum3",
    "description": "B3_7r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r8dum3",
    "description": "B3_7r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r9dum3",
    "description": "B3_7r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r10dum3",
    "description": "B3_7r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r11dum3",
    "description": "B3_7r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r1dum4",
    "description": "B3_7r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r2dum4",
    "description": "B3_7r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r3dum4",
    "description": "B3_7r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r4dum4",
    "description": "B3_7r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r5dum4",
    "description": "B3_7r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r6dum4",
    "description": "B3_7r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r7dum4",
    "description": "B3_7r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r8dum4",
    "description": "B3_7r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r9dum4",
    "description": "B3_7r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r10dum4",
    "description": "B3_7r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r11dum4",
    "description": "B3_7r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r1dum5",
    "description": "B3_7r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r2dum5",
    "description": "B3_7r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r3dum5",
    "description": "B3_7r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r4dum5",
    "description": "B3_7r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r5dum5",
    "description": "B3_7r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r6dum5",
    "description": "B3_7r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r7dum5",
    "description": "B3_7r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r8dum5",
    "description": "B3_7r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r9dum5",
    "description": "B3_7r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r10dum5",
    "description": "B3_7r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_7r11dum5",
    "description": "B3_7r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r1c1",
    "description": "B3_8r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r2c1",
    "description": "B3_8r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r3c1",
    "description": "B3_8r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r4c1",
    "description": "B3_8r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r5c1",
    "description": "B3_8r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r6c1",
    "description": "B3_8r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r7c1",
    "description": "B3_8r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r8c1",
    "description": "B3_8r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r9c1",
    "description": "B3_8r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r10c1",
    "description": "B3_8r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r11c1",
    "description": "B3_8r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r1c2",
    "description": "B3_8r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r2c2",
    "description": "B3_8r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r3c2",
    "description": "B3_8r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r4c2",
    "description": "B3_8r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r5c2",
    "description": "B3_8r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r6c2",
    "description": "B3_8r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r7c2",
    "description": "B3_8r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r8c2",
    "description": "B3_8r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r9c2",
    "description": "B3_8r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r10c2",
    "description": "B3_8r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r11c2",
    "description": "B3_8r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_8",
    "context": ""
  },
  {
    "column": "B3_8r1dum1",
    "description": "B3_8r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r2dum1",
    "description": "B3_8r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r3dum1",
    "description": "B3_8r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r4dum1",
    "description": "B3_8r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r5dum1",
    "description": "B3_8r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r6dum1",
    "description": "B3_8r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r7dum1",
    "description": "B3_8r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r8dum1",
    "description": "B3_8r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r9dum1",
    "description": "B3_8r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r10dum1",
    "description": "B3_8r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r11dum1",
    "description": "B3_8r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r1dum2",
    "description": "B3_8r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r2dum2",
    "description": "B3_8r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r3dum2",
    "description": "B3_8r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r4dum2",
    "description": "B3_8r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r5dum2",
    "description": "B3_8r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r6dum2",
    "description": "B3_8r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r7dum2",
    "description": "B3_8r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r8dum2",
    "description": "B3_8r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r9dum2",
    "description": "B3_8r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r10dum2",
    "description": "B3_8r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r11dum2",
    "description": "B3_8r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r1dum3",
    "description": "B3_8r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r2dum3",
    "description": "B3_8r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r3dum3",
    "description": "B3_8r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r4dum3",
    "description": "B3_8r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r5dum3",
    "description": "B3_8r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r6dum3",
    "description": "B3_8r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r7dum3",
    "description": "B3_8r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r8dum3",
    "description": "B3_8r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r9dum3",
    "description": "B3_8r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r10dum3",
    "description": "B3_8r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r11dum3",
    "description": "B3_8r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r1dum4",
    "description": "B3_8r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r2dum4",
    "description": "B3_8r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r3dum4",
    "description": "B3_8r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r4dum4",
    "description": "B3_8r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r5dum4",
    "description": "B3_8r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r6dum4",
    "description": "B3_8r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r7dum4",
    "description": "B3_8r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r8dum4",
    "description": "B3_8r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r9dum4",
    "description": "B3_8r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r10dum4",
    "description": "B3_8r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r11dum4",
    "description": "B3_8r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r1dum5",
    "description": "B3_8r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r2dum5",
    "description": "B3_8r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r3dum5",
    "description": "B3_8r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r4dum5",
    "description": "B3_8r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r5dum5",
    "description": "B3_8r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r6dum5",
    "description": "B3_8r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r7dum5",
    "description": "B3_8r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r8dum5",
    "description": "B3_8r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r9dum5",
    "description": "B3_8r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r10dum5",
    "description": "B3_8r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_8r11dum5",
    "description": "B3_8r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r1c1",
    "description": "B3_9r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r2c1",
    "description": "B3_9r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r3c1",
    "description": "B3_9r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r4c1",
    "description": "B3_9r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r5c1",
    "description": "B3_9r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r6c1",
    "description": "B3_9r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r7c1",
    "description": "B3_9r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r8c1",
    "description": "B3_9r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r9c1",
    "description": "B3_9r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r10c1",
    "description": "B3_9r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r11c1",
    "description": "B3_9r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r1c2",
    "description": "B3_9r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r2c2",
    "description": "B3_9r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r3c2",
    "description": "B3_9r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r4c2",
    "description": "B3_9r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r5c2",
    "description": "B3_9r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r6c2",
    "description": "B3_9r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r7c2",
    "description": "B3_9r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r8c2",
    "description": "B3_9r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r9c2",
    "description": "B3_9r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r10c2",
    "description": "B3_9r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r11c2",
    "description": "B3_9r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_9",
    "context": ""
  },
  {
    "column": "B3_9r1dum1",
    "description": "B3_9r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r2dum1",
    "description": "B3_9r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r3dum1",
    "description": "B3_9r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r4dum1",
    "description": "B3_9r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r5dum1",
    "description": "B3_9r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r6dum1",
    "description": "B3_9r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r7dum1",
    "description": "B3_9r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r8dum1",
    "description": "B3_9r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r9dum1",
    "description": "B3_9r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r10dum1",
    "description": "B3_9r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r11dum1",
    "description": "B3_9r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r1dum2",
    "description": "B3_9r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r2dum2",
    "description": "B3_9r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r3dum2",
    "description": "B3_9r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r4dum2",
    "description": "B3_9r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r5dum2",
    "description": "B3_9r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r6dum2",
    "description": "B3_9r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r7dum2",
    "description": "B3_9r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r8dum2",
    "description": "B3_9r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r9dum2",
    "description": "B3_9r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r10dum2",
    "description": "B3_9r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r11dum2",
    "description": "B3_9r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r1dum3",
    "description": "B3_9r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r2dum3",
    "description": "B3_9r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r3dum3",
    "description": "B3_9r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r4dum3",
    "description": "B3_9r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r5dum3",
    "description": "B3_9r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r6dum3",
    "description": "B3_9r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r7dum3",
    "description": "B3_9r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r8dum3",
    "description": "B3_9r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r9dum3",
    "description": "B3_9r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r10dum3",
    "description": "B3_9r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r11dum3",
    "description": "B3_9r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r1dum4",
    "description": "B3_9r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r2dum4",
    "description": "B3_9r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r3dum4",
    "description": "B3_9r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r4dum4",
    "description": "B3_9r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r5dum4",
    "description": "B3_9r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r6dum4",
    "description": "B3_9r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r7dum4",
    "description": "B3_9r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r8dum4",
    "description": "B3_9r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r9dum4",
    "description": "B3_9r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r10dum4",
    "description": "B3_9r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r11dum4",
    "description": "B3_9r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r1dum5",
    "description": "B3_9r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r2dum5",
    "description": "B3_9r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r3dum5",
    "description": "B3_9r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r4dum5",
    "description": "B3_9r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r5dum5",
    "description": "B3_9r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r6dum5",
    "description": "B3_9r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r7dum5",
    "description": "B3_9r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r8dum5",
    "description": "B3_9r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r9dum5",
    "description": "B3_9r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r10dum5",
    "description": "B3_9r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_9r11dum5",
    "description": "B3_9r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r1c1",
    "description": "B3_10r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r2c1",
    "description": "B3_10r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r3c1",
    "description": "B3_10r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r4c1",
    "description": "B3_10r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r5c1",
    "description": "B3_10r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r6c1",
    "description": "B3_10r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r7c1",
    "description": "B3_10r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r8c1",
    "description": "B3_10r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r9c1",
    "description": "B3_10r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r10c1",
    "description": "B3_10r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r11c1",
    "description": "B3_10r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r1c2",
    "description": "B3_10r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r2c2",
    "description": "B3_10r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r3c2",
    "description": "B3_10r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r4c2",
    "description": "B3_10r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r5c2",
    "description": "B3_10r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r6c2",
    "description": "B3_10r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r7c2",
    "description": "B3_10r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r8c2",
    "description": "B3_10r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r9c2",
    "description": "B3_10r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r10c2",
    "description": "B3_10r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r11c2",
    "description": "B3_10r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_10",
    "context": ""
  },
  {
    "column": "B3_10r1dum1",
    "description": "B3_10r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r2dum1",
    "description": "B3_10r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r3dum1",
    "description": "B3_10r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r4dum1",
    "description": "B3_10r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r5dum1",
    "description": "B3_10r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r6dum1",
    "description": "B3_10r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r7dum1",
    "description": "B3_10r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r8dum1",
    "description": "B3_10r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r9dum1",
    "description": "B3_10r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r10dum1",
    "description": "B3_10r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r11dum1",
    "description": "B3_10r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r1dum2",
    "description": "B3_10r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r2dum2",
    "description": "B3_10r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r3dum2",
    "description": "B3_10r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r4dum2",
    "description": "B3_10r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r5dum2",
    "description": "B3_10r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r6dum2",
    "description": "B3_10r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r7dum2",
    "description": "B3_10r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r8dum2",
    "description": "B3_10r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r9dum2",
    "description": "B3_10r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r10dum2",
    "description": "B3_10r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r11dum2",
    "description": "B3_10r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r1dum3",
    "description": "B3_10r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r2dum3",
    "description": "B3_10r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r3dum3",
    "description": "B3_10r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r4dum3",
    "description": "B3_10r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r5dum3",
    "description": "B3_10r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r6dum3",
    "description": "B3_10r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r7dum3",
    "description": "B3_10r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r8dum3",
    "description": "B3_10r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r9dum3",
    "description": "B3_10r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r10dum3",
    "description": "B3_10r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r11dum3",
    "description": "B3_10r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r1dum4",
    "description": "B3_10r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r2dum4",
    "description": "B3_10r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r3dum4",
    "description": "B3_10r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r4dum4",
    "description": "B3_10r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r5dum4",
    "description": "B3_10r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r6dum4",
    "description": "B3_10r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r7dum4",
    "description": "B3_10r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r8dum4",
    "description": "B3_10r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r9dum4",
    "description": "B3_10r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r10dum4",
    "description": "B3_10r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r11dum4",
    "description": "B3_10r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r1dum5",
    "description": "B3_10r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r2dum5",
    "description": "B3_10r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r3dum5",
    "description": "B3_10r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r4dum5",
    "description": "B3_10r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r5dum5",
    "description": "B3_10r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r6dum5",
    "description": "B3_10r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r7dum5",
    "description": "B3_10r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r8dum5",
    "description": "B3_10r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r9dum5",
    "description": "B3_10r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r10dum5",
    "description": "B3_10r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_10r11dum5",
    "description": "B3_10r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r1c1",
    "description": "B3_11r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r2c1",
    "description": "B3_11r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r3c1",
    "description": "B3_11r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r4c1",
    "description": "B3_11r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r5c1",
    "description": "B3_11r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r6c1",
    "description": "B3_11r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r7c1",
    "description": "B3_11r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r8c1",
    "description": "B3_11r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r9c1",
    "description": "B3_11r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r10c1",
    "description": "B3_11r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r11c1",
    "description": "B3_11r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r1c2",
    "description": "B3_11r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r2c2",
    "description": "B3_11r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r3c2",
    "description": "B3_11r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r4c2",
    "description": "B3_11r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r5c2",
    "description": "B3_11r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r6c2",
    "description": "B3_11r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r7c2",
    "description": "B3_11r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r8c2",
    "description": "B3_11r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r9c2",
    "description": "B3_11r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r10c2",
    "description": "B3_11r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r11c2",
    "description": "B3_11r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_11",
    "context": ""
  },
  {
    "column": "B3_11r1dum1",
    "description": "B3_11r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r2dum1",
    "description": "B3_11r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r3dum1",
    "description": "B3_11r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r4dum1",
    "description": "B3_11r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r5dum1",
    "description": "B3_11r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r6dum1",
    "description": "B3_11r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r7dum1",
    "description": "B3_11r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r8dum1",
    "description": "B3_11r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r9dum1",
    "description": "B3_11r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r10dum1",
    "description": "B3_11r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r11dum1",
    "description": "B3_11r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r1dum2",
    "description": "B3_11r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r2dum2",
    "description": "B3_11r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r3dum2",
    "description": "B3_11r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r4dum2",
    "description": "B3_11r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r5dum2",
    "description": "B3_11r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r6dum2",
    "description": "B3_11r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r7dum2",
    "description": "B3_11r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r8dum2",
    "description": "B3_11r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r9dum2",
    "description": "B3_11r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r10dum2",
    "description": "B3_11r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r11dum2",
    "description": "B3_11r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r1dum3",
    "description": "B3_11r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r2dum3",
    "description": "B3_11r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r3dum3",
    "description": "B3_11r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r4dum3",
    "description": "B3_11r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r5dum3",
    "description": "B3_11r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r6dum3",
    "description": "B3_11r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r7dum3",
    "description": "B3_11r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r8dum3",
    "description": "B3_11r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r9dum3",
    "description": "B3_11r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r10dum3",
    "description": "B3_11r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r11dum3",
    "description": "B3_11r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r1dum4",
    "description": "B3_11r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r2dum4",
    "description": "B3_11r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r3dum4",
    "description": "B3_11r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r4dum4",
    "description": "B3_11r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r5dum4",
    "description": "B3_11r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r6dum4",
    "description": "B3_11r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r7dum4",
    "description": "B3_11r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r8dum4",
    "description": "B3_11r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r9dum4",
    "description": "B3_11r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r10dum4",
    "description": "B3_11r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r11dum4",
    "description": "B3_11r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r1dum5",
    "description": "B3_11r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r2dum5",
    "description": "B3_11r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r3dum5",
    "description": "B3_11r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r4dum5",
    "description": "B3_11r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r5dum5",
    "description": "B3_11r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r6dum5",
    "description": "B3_11r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r7dum5",
    "description": "B3_11r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r8dum5",
    "description": "B3_11r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r9dum5",
    "description": "B3_11r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r10dum5",
    "description": "B3_11r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_11r11dum5",
    "description": "B3_11r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r1c1",
    "description": "B3_12r1c1: Leqvio - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r2c1",
    "description": "B3_12r2c1: PRALUENT - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r3c1",
    "description": "B3_12r3c1: REPATHA - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r4c1",
    "description": "B3_12r4c1: Product W - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r5c1",
    "description": "B3_12r5c1: Product X - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r6c1",
    "description": "B3_12r6c1: Product Y - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r7c1",
    "description": "B3_12r7c1: Product Z - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r8c1",
    "description": "B3_12r8c1: NEXLETOL / NEXLIZET - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r9c1",
    "description": "B3_12r9c1: ZETIA (ezetimibe) - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r10c1",
    "description": "B3_12r10c1: Other treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r11c1",
    "description": "B3_12r11c1: No additional treatment - Original Allocation - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r1c2",
    "description": "B3_12r1c2: Leqvio - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r2c2",
    "description": "B3_12r2c2: PRALUENT - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r3c2",
    "description": "B3_12r3c2: REPATHA - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r4c2",
    "description": "B3_12r4c2: Product W - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r5c2",
    "description": "B3_12r5c2: Product X - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r6c2",
    "description": "B3_12r6c2: Product Y - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r7c2",
    "description": "B3_12r7c2: Product Z - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r8c2",
    "description": "B3_12r8c2: NEXLETOL / NEXLIZET - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r9c2",
    "description": "B3_12r9c2: ZETIA (ezetimibe) - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r10c2",
    "description": "B3_12r10c2: Other treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r11c2",
    "description": "B3_12r11c2: No additional treatment - Next 100 Patients - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B3_12",
    "context": ""
  },
  {
    "column": "B3_12r1dum1",
    "description": "B3_12r1dum1: Leqvio - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r2dum1",
    "description": "B3_12r2dum1: PRALUENT - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r3dum1",
    "description": "B3_12r3dum1: REPATHA - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r4dum1",
    "description": "B3_12r4dum1: Product W - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r5dum1",
    "description": "B3_12r5dum1: Product X - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r6dum1",
    "description": "B3_12r6dum1: Product Y - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r7dum1",
    "description": "B3_12r7dum1: Product Z - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r8dum1",
    "description": "B3_12r8dum1: NEXLETOL / NEXLIZET - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r9dum1",
    "description": "B3_12r9dum1: ZETIA (ezetimibe) - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r10dum1",
    "description": "B3_12r10dum1: Other treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r11dum1",
    "description": "B3_12r11dum1: No additional treatment - Product - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r1dum2",
    "description": "B3_12r1dum2: Leqvio - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r2dum2",
    "description": "B3_12r2dum2: PRALUENT - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r3dum2",
    "description": "B3_12r3dum2: REPATHA - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r4dum2",
    "description": "B3_12r4dum2: Product W - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r5dum2",
    "description": "B3_12r5dum2: Product X - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r6dum2",
    "description": "B3_12r6dum2: Product Y - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r7dum2",
    "description": "B3_12r7dum2: Product Z - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r8dum2",
    "description": "B3_12r8dum2: NEXLETOL / NEXLIZET - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r9dum2",
    "description": "B3_12r9dum2: ZETIA (ezetimibe) - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r10dum2",
    "description": "B3_12r10dum2: Other treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r11dum2",
    "description": "B3_12r11dum2: No additional treatment - MOA - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r1dum3",
    "description": "B3_12r1dum3: Leqvio - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r2dum3",
    "description": "B3_12r2dum3: PRALUENT - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r3dum3",
    "description": "B3_12r3dum3: REPATHA - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r4dum3",
    "description": "B3_12r4dum3: Product W - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r5dum3",
    "description": "B3_12r5dum3: Product X - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r6dum3",
    "description": "B3_12r6dum3: Product Y - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r7dum3",
    "description": "B3_12r7dum3: Product Z - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r8dum3",
    "description": "B3_12r8dum3: NEXLETOL / NEXLIZET - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r9dum3",
    "description": "B3_12r9dum3: ZETIA (ezetimibe) - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r10dum3",
    "description": "B3_12r10dum3: Other treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r11dum3",
    "description": "B3_12r11dum3: No additional treatment - Dosing - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r1dum4",
    "description": "B3_12r1dum4: Leqvio - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r2dum4",
    "description": "B3_12r2dum4: PRALUENT - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r3dum4",
    "description": "B3_12r3dum4: REPATHA - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r4dum4",
    "description": "B3_12r4dum4: Product W - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r5dum4",
    "description": "B3_12r5dum4: Product X - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r6dum4",
    "description": "B3_12r6dum4: Product Y - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r7dum4",
    "description": "B3_12r7dum4: Product Z - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r8dum4",
    "description": "B3_12r8dum4: NEXLETOL / NEXLIZET - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r9dum4",
    "description": "B3_12r9dum4: ZETIA (ezetimibe) - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r10dum4",
    "description": "B3_12r10dum4: Other treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r11dum4",
    "description": "B3_12r11dum4: No additional treatment - Indication - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r1dum5",
    "description": "B3_12r1dum5: Leqvio - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r2dum5",
    "description": "B3_12r2dum5: PRALUENT - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r3dum5",
    "description": "B3_12r3dum5: REPATHA - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r4dum5",
    "description": "B3_12r4dum5: Product W - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r5dum5",
    "description": "B3_12r5dum5: Product X - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r6dum5",
    "description": "B3_12r6dum5: Product Y - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r7dum5",
    "description": "B3_12r7dum5: Product Z - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r8dum5",
    "description": "B3_12r8dum5: NEXLETOL / NEXLIZET - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r9dum5",
    "description": "B3_12r9dum5: ZETIA (ezetimibe) - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r10dum5",
    "description": "B3_12r10dum5: Other treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B3_12r11dum5",
    "description": "B3_12r11dum5: No additional treatment - Efficacy - To be used on top of maximally tolerated statin therapy for: Colored Text=differences from current clinical profile",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "C2b",
    "description": "C2b: You can click on the image to enlarge.[rel Product_Y_v2.png]If you assume this product did not require a prior authorization, by how much might that increase your prescribing of the product?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "C5ar1c1",
    "description": "C5ar1c1: Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - Thinking more broadly about the patient types we have been reviewing in this survey, please estimate what % of those patients are currentl",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "C5a",
    "context": ""
  },
  {
    "column": "C5ar1c2",
    "description": "C5ar1c2: Adults with low to medium risk for CV events (without a prior event) - Thinking more broadly about the patient types we have been reviewing in this survey, please estimate what % of those patients are currently taking a GLP-1 inhibitor (e.g., Oze",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "C5a",
    "context": ""
  },
  {
    "column": "D1r1c1",
    "description": "D1r1c1: <70 mg/dL - Distribution of hypercholesterolemia patients based on *baseline LDL-C, prior to ANY prescription medication(s), including statins*\"BEFORE\" - Thank you for your time so far. Just a few more questions…For this next question, we'd like",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D1",
    "context": ""
  },
  {
    "column": "D1r2c1",
    "description": "D1r2c1: 70-100 mg/dL - Distribution of hypercholesterolemia patients based on *baseline LDL-C, prior to ANY prescription medication(s), including statins*\"BEFORE\" - Thank you for your time so far. Just a few more questions…For this next question, we'd l",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D1",
    "context": ""
  },
  {
    "column": "D1r3c1",
    "description": "D1r3c1: 101-130 mg/dL - Distribution of hypercholesterolemia patients based on *baseline LDL-C, prior to ANY prescription medication(s), including statins*\"BEFORE\" - Thank you for your time so far. Just a few more questions…For this next question, we'd",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D1",
    "context": ""
  },
  {
    "column": "D1r4c1",
    "description": "D1r4c1: >130 mg/dL - Distribution of hypercholesterolemia patients based on *baseline LDL-C, prior to ANY prescription medication(s), including statins*\"BEFORE\" - Thank you for your time so far. Just a few more questions…For this next question, we'd lik",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D1",
    "context": ""
  },
  {
    "column": "D1r1c2",
    "description": "D1r1c2: <70 mg/dL - Distribution of hypercholesterolemia patients based on *current LDL-C levels as a result of prescription medication(s)*\"AFTER\" - Thank you for your time so far. Just a few more questions…For this next question, we'd like to understan",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D1",
    "context": ""
  },
  {
    "column": "D1r2c2",
    "description": "D1r2c2: 70-100 mg/dL - Distribution of hypercholesterolemia patients based on *current LDL-C levels as a result of prescription medication(s)*\"AFTER\" - Thank you for your time so far. Just a few more questions…For this next question, we'd like to unders",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D1",
    "context": ""
  },
  {
    "column": "D1r3c2",
    "description": "D1r3c2: 101-130 mg/dL - Distribution of hypercholesterolemia patients based on *current LDL-C levels as a result of prescription medication(s)*\"AFTER\" - Thank you for your time so far. Just a few more questions…For this next question, we'd like to under",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D1",
    "context": ""
  },
  {
    "column": "D1r4c2",
    "description": "D1r4c2: >130 mg/dL - Distribution of hypercholesterolemia patients based on *current LDL-C levels as a result of prescription medication(s)*\"AFTER\" - Thank you for your time so far. Just a few more questions…For this next question, we'd like to understa",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D1",
    "context": ""
  },
  {
    "column": "D9",
    "description": "D9: What % of your patients with established cardiovascular disease (CVD) (e.g., MI, stroke, or symptomatic PAD) require injectable therapy (e.g., Repatha, Leqvio, Praluent) to control their LDL-C?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "D3r1c1",
    "description": "D3r1c1: Not insured - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r2c1",
    "description": "D3r2c1: Private insurance provided by employer / purchased in exchange - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insur",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r3c1",
    "description": "D3r3c1: Traditional Medicare (Medicare Part B Fee for Service) - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r4c1",
    "description": "D3r4c1: Traditional Medicare with supplemental insurance - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r5c1",
    "description": "D3r5c1: Private Medicare (Medicare Advantage / Part C managed through Private payer) - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - What percentage of your current patients are covered by each",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r6c1",
    "description": "D3r6c1: Medicaid - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r7c1",
    "description": "D3r7c1: Veterans Administration (VA) - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r8c1",
    "description": "D3r8c1: Other - Adults with established CVD (with history of event) or at high risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r1c2",
    "description": "D3r1c2: Not insured - Adults with low to medium risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r2c2",
    "description": "D3r2c2: Private insurance provided by employer / purchased in exchange - Adults with low to medium risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r3c2",
    "description": "D3r3c2: Traditional Medicare (Medicare Part B Fee for Service) - Adults with low to medium risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r4c2",
    "description": "D3r4c2: Traditional Medicare with supplemental insurance - Adults with low to medium risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r5c2",
    "description": "D3r5c2: Private Medicare (Medicare Advantage / Part C managed through Private payer) - Adults with low to medium risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r6c2",
    "description": "D3r6c2: Medicaid - Adults with low to medium risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r7c2",
    "description": "D3r7c2: Veterans Administration (VA) - Adults with low to medium risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D3r8c2",
    "description": "D3r8c2: Other - Adults with low to medium risk for CV events (without a prior event) - What percentage of your current patients are covered by each type of insurance?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "D3",
    "context": ""
  },
  {
    "column": "D6",
    "description": "D6: How many physicians are in your practice?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  }
]